Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27286102)

Published in Int Braz J Urol on June 11, 2016

Authors

Nishanth Krishnananthan1, Nathan Lawrentschuk1,2,3

Author Affiliations

1: University of Melbourne, Department of Surgery, Austin Health, Melbourne, Australia.
2: Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
3: Olivia Newton-John Cancer Research Institute, Melbourne, Australia.

Articles cited by this

Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med (2012) 24.06

Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med (2014) 10.06

Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73

Outcomes of localized prostate cancer following conservative management. JAMA (2009) 5.57

Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol (2014) 5.01

Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol (2012) 3.07

Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol (2009) 2.39

Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer (2013) 1.97

Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study. Eur Urol (2012) 1.96

Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review. Eur Urol (2014) 1.83

Active surveillance for the management of localized prostate cancer: Guideline recommendations. Can Urol Assoc J (2015) 1.38

The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry. BJU Int (2015) 1.19

Active surveillance for clinically localized prostate cancer--a systematic review. J Surg Oncol (2014) 1.09

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol (2016) 1.04

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients. Urol Oncol (2014) 0.93

Active surveillance: the Canadian experience with an "inclusive approach". J Natl Cancer Inst Monogr (2012) 0.92

Long-term active surveillance for prostate cancer: answers and questions. J Clin Oncol (2014) 0.84

Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer. Curr Opin Urol (2014) 0.83

Gleason pattern 4: active surveillance no more. BJU Int (2015) 0.80